1.
s.l; s.n; 2002. 3 p.
No convencional
en Inglés
| Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1238814
2.
s.l; s.n; 1992. 3 p.
No convencional
en Inglés
| Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1236526
3.
s.l; s.n; 1991. 4 p. tab, graf.
No convencional
en Inglés
| Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1236654
Asunto(s)
Adolescente , Anticuerpos Antibacterianos/análisis , Anticuerpos Monoclonales/análisis , Biomarcadores/sangre , Enfermedades del Sistema Nervioso Periférico/inmunología , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Factores de Riesgo , Glucolípidos/inmunología , Lepra Dimorfa/inmunología , Lepra Dimorfa/tratamiento farmacológico , Lepra Tuberculoide/tratamiento farmacológico , Hipersensibilidad a las Drogas/etiología , Hipersensibilidad a las Drogas/inmunología , Inmunidad Celular , Lipopolisacáridos/inmunología , Mycobacterium leprae/inmunología , Neuritas/inmunología , Neuritas/inducido químicamente , Pruebas Intradérmicas
4.
s.l; s.n; feb. 1983. 7 p. tab.
No convencional
en Alemán
| Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1240431
RESUMEN
Based on present publications we review indications of the therapy of dermatoses with thalidomide as well as possible mechanisms of action and side effects of this drug. In reactional states of leprosy the use of thalidomide is established. Further indications are chronic cutaneous lupus erythematosus, prurigo nodularis, and eventually recurrent aphthosis and certain photodermatoses not responding to usual treatment. Therapeutical trials of thalidomide in diseases in which such a treatment is only occasionally or not at all mentioned in the literature will be reported. Concerning the mechanisms of action emphasis is put on a possible immunosuppression by thalidomide. Among the side effects the thalidomide neuropathy is stressed.